Global Burden of Polycystic Ovary Syndrome: Socioeconomic Disparities, Reproductive Impacts, and Projections to 2050
- 8 March 2026
- journal article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 31 (6) , 669-715
Abstract
Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age, affecting 11%–13% globally and representing a primary cause of anovulatory infertility, with substantial socioeconomic disparities influencing its worldwide burden. However, data on temporal trends, regional variations, and sociodemographic drivers of PCOS are limited. We aimed to evaluate global, regional, and national PCOS trends from 1990 to 2021 and project future impacts to 2050. Methods: In this trend analysis based on the 2021 Global Burden of Diseases (GBD) study, we report on the prevalence, incidence, and years lived with disability (YLDs) rates per 100,000 individuals, as well as average annual percentage changes (AAPCs) for PCOS at the global, regional, and national levels. We analyzed these trends by age, SDI, and reproductive outcomes using age‐period‐cohort (APC) modelling, decomposition, inequality analysis, and Bayesian projections. Results: From 1990 to 2021, global PCOS prevalent cases increased from 36.65 million to 69.47 million (89.6% rise), with an age‐standardised prevalence rate (ASPR) of 1757.8 per 100,000 in 2021 (AAPC 0.81 [95% CI 0.77–0.85]). High‐middle SDI regions exhibited the highest burden (ASPR: 5237.6 per 100,000), while low‐SDI regions showed the steepest rise (AAPC: 2.22). Infertility accounted for the majority of YLDs, peaking at ages 25–29. Socioeconomic inequalities decreased (Slope Index of Inequality from 28.55 to 22.28). Projections indicate 103.91 million cases by 2050. Conclusion: From 1990 to 2021, global PCOS burden increased substantially, with marked socioeconomic and regional disparities. This underscores the need for enhanced screening, personalised treatments, and targeted interventions in low‐SDI regions to promote reproductive health equity.Keywords
Funding Information
- National Natural Science Foundation of China (82370903)
This publication has 34 references indexed in Scilit:
- Weight Management Strategies to Reduce Metabolic Morbidity in Women With Polycystic Ovary SyndromeCurrent Obesity Reports, 2025
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary SyndromeFertility and Sterility, 2023
- Racial and ethnic disparities in polycystic ovary syndromeFertility and Sterility, 2023
- A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage onMetabolism, 2022
- Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional studyAmerican Journal of Obstetrics and Gynecology, 2017
- Projecting the future burden of cancer: Bayesian age–period–cohort analysis with integrated nested Laplace approximationsBiometrical Journal, 2017
- Environmental determinants of polycystic ovary syndromeFertility and Sterility, 2016
- Polycystic ovary syndrome is associated with genetic polymorphism in the insulin signaling gene IRS-1 but not ENPP1 in a Japanese populationLife Sciences, 2007
- A welfare economics foundation for health inequality measurementJournal of Health Economics, 2006
- Permutation tests for joinpoint regression with applications to cancer ratesStatistics in Medicine, 2000